|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Net Revenue | |
| Cost of Goods Sold | |
| Gross Profit | |
| Selling, general, and administrative expenses | |
| Research and development expenses | |
| Operating Loss | |
| Other Expense | |
| Interest expense, net | |
| Change in fair value of convertible notes, net | |
| Change in fair value of Series E purchase option | |
| Other (income) expense, net | |
| Total Other Expense | |
| Loss before income tax expense | |
| Income Tax Expense | |
| Net Loss | |
| Other Comprehensive loss, net | |
| Unrealized loss on marketable securities | |
| Total Other Comprehensive loss, net | |
| Comprehensive loss | |
| Net loss per share attributed to common stock – basic and diluted: | |
| Net loss per share (in dollars per share) | |
| Weighted average shares outstanding: | |
| Weighted average common shares outstanding – basic (in shares) | |
| Weighted average common shares outstanding – diluted (in shares) |
Loading...
